Las Vegas, NV -- (SBWIRE) -- 11/01/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Sprint Corporation (NYSE:S), Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT), Sequenom, Inc. (NASDAQ:SQNM), Amarin Corporation plc (ADR) (NASDAQ:AMRN)
Sprint Corporation (NYSE:S) managed to keep its fall at -2.89% on above-normal volume of 22.M shares. The stock settled at $6.73 after floating in a range of $6.67 to $6.89. Its latest price has reached market capitalization of $27.22 billion. Its 52-week range has been $5.15 to $7.26. print Corporation provides wireless and wireline communications services to consumers, businesses, and government users in the United States, Puerto Rico, and the U.S. Virgin Islands. It operates in two segments, Wireless and Wireline.
Has S Found The Bottom and Ready To Move Up? Find Out Here
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) traded up on a volume of 16.73 million, higher than its standard daily volume. Shares have gained 8.19% to $3.04. Over the last twelve months, the stock has lost -85.1% and faced a worst price of $1.19. Oxygen Biotherapeutics, Inc. (Oxygen Biotherapeutics) is engaged in the business of developing biotechnology products with a focus on oxygen delivery to tissue.
For How Long OXBT’s Gloss will Attract Investors? Find out via this report
Sequenom, Inc. (NASDAQ:SQNM) settled -22.58% lower at $1.92 on above-normal volume of 15.13M shares during the last trading day. The stock has its 12-month high at $5.36 and 52-week low price was $1.70. It traded in a range of $1.70 to $2.47 during the last trading day. Sequenom, Inc. (Sequenom) is a molecular diagnostic testing and genetics analysis company committed to providing molecular diagnostic testing services, and research use only products, services, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research.
Will SQNM Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Amarin Corporation plc (ADR) (NASDAQ:AMRN) was down on high volume, trading at a volume of 14.82M shares versus its average daily volume of 12.563 million shares. At $1.65, the stock has attained market capitalization of $284.04 million. Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease.
Why Should Investors Buy AMRN After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)